Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Promyelocytic, Acute 5Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3Leukemia 3Small Cell Lung Carcinoma 2Melanoma 2Prostatic Neoplasms 1Primary Myelofibrosis 1Multiple Myeloma 1Lung Neoplasms 1Hematologic Neoplasms 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenoid Cystic 1Adenocarcinoma of Lung 1

Interventions

merphos 1azathiopurine 1arsenous acid 1Tretinoin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Cytarabine 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Childhood Acute Promyelocytic Leukemia With PML-RARA × Tretinoin × Clear all
NCT00866918 2022-10-25

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

Children's Oncology Group

Phase 3 Completed
106 enrolled 14 charts
MyeloidOther hematologic neoplasm

Childhood Acute Promyelocytic Leukemia With PML-RARA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡